Suzhou Basecare Medical Corp. Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Vincent Medical Holdings Ltd.

China Isotope & Radiation Corp.

PW Medtech Group Ltd.

Uni-Bio Science Group Ltd.

Essex Bio-Technology Ltd.

Beijing Chunlizhengda Medical Instruments Co., Ltd.

Shanghai Heartcare Medical Technology Corp. Ltd.

Elegance Optical International Holdings Ltd.

Broncus Holding Corp.

Suzhou Basecare Medical Corp. Ltd.

Kelfred Holdings Ltd.

Why is Suzhou Basecare Medical Corp. Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%

Poor long term growth as Net Sales has grown by an annual rate of 25.17% and Operating profit at -21.19% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -120.60

Negative results in Dec 24

ROCE(HY) Lowest at -18.64%
DEBT-EQUITY RATIO (HY) Highest at -31.28 %
CASH AND EQV(HY) Lowest at HKD 730.04 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -29.00%, its profits have fallen by -22.1%

Below par performance in long term as well as near term

Along with generating -29.00% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Suzhou Basecare Medical Corp. Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Suzhou Basecare Medical Corp. Ltd.

-29.0%

0.11

59.08%

Hang Seng Hong Kong

27.36%

1.06

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

25.17%

EBIT Growth (5y)

-21.19%

EBIT to Interest (avg)

-120.60

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.11

Tax Ratio

1.30%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.26

EV to EBIT

2.10

EV to EBITDA

2.36

EV to Capital Employed

-0.08

EV to Sales

-1.13

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-3.76%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Suzhou Basecare Medical Corp. Ltd.

Net Sales

Highest at HKD 189.16 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (HKD MM)

Operating Profit Margin

Highest at -65.37 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Net Profit

Higher at HKD -127.05 MM

than preceding 12 month period ended Dec 2024

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (HKD MM)

Net Sales

At HKD 189.16 MM has Grown at 43.01%

Year on Year (YoY)

MOJO Watch

Near term sales trend is positive

Net Sales (HKD MM)

Debtors Turnover Ratio

Highest at 1.75%

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -13.44% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at HKD 21.63 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 21.63 MM has Grown at 26.75%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for Suzhou Basecare Medical Corp. Ltd.

Debt-Equity Ratio

Highest at -31.28 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest

Highest at HKD 6.17 MM

in the last five periods and Increased by 54.57% (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)

Cash and Eqv

Lowest at HKD 730.04 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents